ASTRO 2017: Aggressive Therapy Fails in High-Risk Endometrial Cancer

In this video, Marcus Randall, MD, of the University of Kentucky College of Medicine, discusses a phase III Gynecologic Oncology Group (GOG) trial that compared pelvic radiation therapy vs vaginal cuff brachytherapy plus paclitaxel/carboplatin in patients with early-stage, high-risk endometrial cancer.

Randall presented results of the study (abstract LBA-1) at the 2017 American Society for Radiation Oncology (ASTRO) Annual Meeting, held September 24–27 in San Diego.